mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.12 |
0.04 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.04 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |